(Press-News.org) A pioneering surgical blood salvage technology developed at the University of Strathclyde, Glasgow, is set to transform the way major surgery is carried out by reducing blood loss in patients.
HemoSep is set to revolutionise the health care sector after gaining the CE mark and receiving Canadian national approval, following highly successful clinical trials in the world leading University of Kirikkale University Hospital in Ankara, Turkey.
The device is designed to recover blood spilled during open-heart and major trauma surgery and concentrate the blood cells for transfusion back to the patient. This process, known as autotransfusion, reduces the volume of donor blood required and the problems associated with transfusion reaction.
Professor Terry Gourlay, who led the development of the technology at the University's Department of Biomedical Engineering, said: "This is a fantastic example of real collaboration between the University of Strathclyde and the medical device industry to take this device from concept to clinical delivery.
"The introduction of HemoSep to the medical device field will make a significant difference to people's lives and greatly reduce the cost and risks associated with blood transfusions. The technology has distinct advantages over traditional techniques which are not only costly but technically challenging and involve the use of a complex centrifuge and pumping apparatus by specialist technicians.
"We expect further developments in the form of a derivative of this technology for use in children undergoing open-heart surgery where the challenges of blood conservation are even more critical."
In the clinical trials, carried out in over 100 open-heart surgery operations, the use of the HemoSep device significantly reduced the need for blood transfusions together with preservation of normal clotting mechanisms and a reduction in the inflammatory reaction often encountered after such surgical procedures.
The device consists of a blood bag which employs a chemical sponge technology and a mechanical agitator to concentrate blood sucked from the surgical site or drained from the heart-lung machine after the surgery. The separated cells are then returned to the patient by intravenous transfusion.
Professor Serdar Gunaydin, Head of Cardiac Surgery at the University of Kirikkale where the trials were conducted, said: "The technology is a real step forward in the field of autotransfusion for cardiac surgery, being highly effective, easy to use and associated with a reduction in the need for donor transfusion and blood loss in these patients.
"In the climate of national blood product shortages and concern for disease transmission and immunosuppression, every effort should be made to optimise blood recovery and reduce allogeneic blood usage.
"The HemoSep technology has produced impressive results, it is the easiest method we have ever used. There is no interference with the ongoing operation and product is ready to use following a very short processing time. It quickly and safely recovers substantial proteins, clotting factors and cell concentrates for all types of cardiac procedures.
"We believe this new technology will be one of the essential components of the routine heart surgery in the near future. We even think this technique may be useful for blood preservation during transplantation, orthopedics and neurosurgery."
Further clinical trials are planned, but the CE mark means that the device will now be sold to the healthcare sector. HemoSep has been licensed to Advancis Surgical Ltd. The company will market and sell the device in all European territories, other regions which recognise the CE mark and Canada.
Mr Stephen Cotton, Advancis Surgical Ltd director of research and development, said: "We are delighted to be able to make this announcement which comes after considerable shared effort to develop this exciting product. We hope that this success will be the first of many through our collaboration with the University of Strathclyde."
Professors Gourlay and Gunaydin will present the results of the recent clinical trials at the European Society for Artificial Organs congress in Rostock, Germany in September to correspond with Advancis' commercial launch of the device.
INFORMATION:
New technology to transform blood processing
2012-08-21
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Dawn of humanity illuminated in special journal edition – 50 years after the Leakeys
2012-08-21
The first systematic, multidisciplinary results to come out of research conducted on the edge of the Serengeti at the rich palaeoanthropological site in the Olduvai Gorge in Tanzania since that produced by Louis and Mary Leakey's team, have recently been published in a special issue of the prestigious Journal of Human Evolution.
Professor Marion Bamford, deputy director of the Bernard Price Institute for Palaeontological Research, and Professor Ron Clarke from the Institute of Human Evolution – both at the University of the Witwatersrand – contributed papers to the 191-page ...
Stem cells can become anything – but not without this protein
2012-08-21
ANN ARBOR, Mich. — How do stem cells preserve their ability to become any type of cell in the body? And how do they "decide" to give up that magical state and start specializing?
If researchers could answer these questions, our ability to harness stem cells to treat disease could explode. Now, a University of Michigan Medical School team has published a key discovery that could help that goal become reality.
In the current issue of the prestigious journal Cell Stem Cell, researcher Yali Dou, Ph.D., and her team show the crucial role of a protein called Mof in preserving ...
Flood risk ranking reveals vulnerable cities
2012-08-21
A new study of nine coastal cities around the world suggests that Shanghai is most vulnerable to serious flooding. European cities top the leader board for their resilience.
These finding are based on a new method to calculate the flood vulnerability of cities, developed by a team of researchers from the Netherlands and the University of Leeds. The work is published in the latest edition of the journal Natural Hazards.
The index does not just look at the likelihood of a city's exposure to a major 'once in a hundred years' flood. The researchers have been careful to ...
Equality laws fail to protect working women from budget cuts
2012-08-21
The UK government has failed to apply laws that protect working women in the wake of the economic crisis, suggests a new study from Queen Mary, University of London.
The article analyses The Fawcett Case, a high-profile legal challenge to the 2010 emergency budget on the grounds that it would have a disproportionately negative impact on women.
The paper also charts how equality legislation has created opportunities for women's rights groups to influence industrial relations; traditionally, trade union territory.
The research was carried out by Dr Hazel Conley, from ...
Language barrier creates legal hurdles for Brits in Turkey
2012-08-21
Many Brits who move to Turkey are failing to grasp local and international laws, leaving them financially at risk when making legal transactions, such as buying property, a study from Queen Mary, University of London has found.
Being unable to speak or read Turkish has made navigating such issues a "legal minefield" for many Brits who emigrate in a quest for the affordable "good life" on the Aegean coast.
Funded by the Nuffield Foundation, the study focuses on British citizens settling in Mugla, a popular tourist spot in Turkey, and their social and legal experiences ...
Catalan researchers identify a key component of cell division
2012-08-21
This press release is available in Spanish and in French
- The Nek9 protein is required for chromosomes to separate into two identical groups.
- Nek9 exerts its action between two molecules of interest for the pharmaceutical industry as anti-tumoral agents, and for which inhibitors are already in advanced stages of clinical trials. Nek9 could be added to the list of candidates.
A study by the Institute for Research in Biomedicine (IRB Barcelona) and the Center for Genomic Regulation (acronym in Catalan CRG) highlights the protein Nek9 as a decisive factor in cell ...
No ordinary forget-me-nots
2012-08-21
Two rare species of forget-me-nots have been added to Flora of New Zealand. These new species were discovered in the mountains of the South Island during an expedition led by Dr. Carlos A. Lehnebach. These new species have been described and illustrated in an article published in the open access journal PhytoKeys.
The expedition was part of a major endeavour by a group of botanists at the Museum of New Zealand Te Papa Tongarewa in partnership with Landcare Research aiming to describe and list all forget-me-nots (Myosotis) found in New Zealand. Dr. Lehnebach, who is a ...
Research identifies mechanism responsible for eye movement disorder
2012-08-21
A research team from King's College London and the University of Exeter Medical School has identified how a genetic mutation acts during the development of nerves responsible for controlling eye muscles, resulting in movement disorders such as Duane Syndrome, a form of squint.
The findings could provide the key to reversing the condition and unlocking the causes of movement disorders in other parts of the body.
The research is published in Proceedings of the National Academy of Sciences.
As nerves develop in the womb they respond to signals that tell them in which ...
Researchers highlight treatment, research needs for homeless families
2012-08-21
A new paper from North Carolina State University calls for more research on how to help homeless families with children who are facing mental-health problems, as well as changes in how shelters are treating these families.
"We wanted to lay out the specific mental-health challenges facing homeless parents and children living in shelters and transitional housing," says Dr. Mary Haskett, a professor of psychology at NC State and co-author of the paper. "This is important, because at any point in time there are approximately one million families with children who are homeless ...
Forest razing by ancient Maya worsened droughts, says study
2012-08-21
For six centuries, the ancient Maya flourished, with more than a hundred city-states scattered across what is now southern Mexico and northern Central America. Then, in A.D. 695, the collapse of several cities in present day Guatemala marked the start of the Classic Maya's slow decline. Prolonged drought is thought to have played a role, but a study published this week in the journal Geophysical Research Letters adds a new twist: The Maya may have made the droughts worse by clearing away forests for cities and crops, making a naturally drying climate drier.
"We're not ...